Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.91
-0.13 (-1.29%)
At close: Jan 9, 2026, 4:00 PM EST
9.89
-0.02 (-0.20%)
After-hours: Jan 9, 2026, 7:00 PM EST
Haleon Employees
Haleon had 24,561 employees as of December 31, 2024. The number of employees decreased by 847 or -3.33% compared to the previous year.
Employees
24,561
Change (1Y)
-847
Growth (1Y)
-3.33%
Revenue / Employee
$614,657
Profits / Employee
$84,900
Market Cap
43.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24,561 | -847 | -3.33% |
| Dec 31, 2023 | 25,408 | 786 | 3.19% |
| Dec 31, 2022 | 24,622 | 1,822 | 7.99% |
| Dec 31, 2021 | 22,800 | 900 | 4.11% |
| Dec 31, 2020 | 21,900 | 2,900 | 15.26% |
| Dec 31, 2019 | 19,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HLN News
- 3 days ago - TUMS Unveils Sweepstakes and Limited-Edition Burn Ball to Help Fans "Pass the TUMS" Ahead of Football's Big Game - PRNewsWire
- 4 weeks ago - Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree - Business Wire
- 4 weeks ago - Haleon: Fairly Priced Given Limited Growth Drivers - Seeking Alpha
- 6 weeks ago - First Eagle Overseas Equity ETF Q3 2025 Portfolio Update - Seeking Alpha
- 2 months ago - Haleon plc (HLN) Q3 2025 Sales Call Transcript - Seeking Alpha
- 2 months ago - UK's Haleon posts third-quarter organic revenue marginally above estimates - Reuters
- 2 months ago - Harding Loevner International Equity ADR Q3 2025 Portfolio Update - Seeking Alpha
- 2 months ago - FTSE 100 Index shares to watch: HSBC, Standard Chartered, Haleon, GSK - Invezz